Sign In
Buy AORT
Artivion Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -73.47. In total, the insiders bought 794.7K and sold 404.23K AORT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-73.47 |
| ● Buy | 794.7K shares |
| ● Sell | 404.23K shares |
|
44% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Dec 03, 2025 Sell |
Holloway Jean F SVP, General Counsel |
5 267 Value: $238.6K |
||
|
Dec 03, 2025 Sell |
Holloway Jean F SVP, General Counsel |
2 048 Value: $92.8K |
||
|
Dec 03, 2025 Buy |
Mackin James P President & CEO |
30 921 Value: $915.9K |
||
|
Dec 03, 2025 Sell |
Mackin James P President & CEO |
30 921 Value: $1.41M |
||
|
Dec 03, 2025 Buy |
Mackin James P President & CEO |
30 921 Value: $915.9K |
||
|
Dec 02, 2025 Buy |
Mackin James P President & CEO |
30 921 Value: $915.9K |
||
|
Dec 02, 2025 Sell |
Mackin James P President & CEO |
30 921 Value: $1.41M |
||
|
Dec 02, 2025 Buy |
Mackin James P President & CEO |
30 921 Value: $915.9K |
||
|
Dec 01, 2025 Sell |
Horton Amy Vp, Chief Accounting Officer |
750 Value: $0 |
||
|
Nov 21, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
20 301 Value: $374.4K |
||
|
Nov 21, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
14 586 Value: $655.2K |
||
|
Nov 21, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
18 705 Value: $840.0K |
||
|
Nov 21, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
27 075 Value: $298.6K |
||
|
Nov 21, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
20 301 Value: $374.4K |
||
|
Nov 21, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
8 370 Value: $379.5K |
||
|
Nov 21, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
5 715 Value: $259.2K |
||
|
Nov 21, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
27 075 Value: $298.6K |
||
|
Nov 20, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
2 033 Value: $37.5K |
||
|
Nov 20, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
1 355 Value: $14.9K |
||
|
Nov 20, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
11 888 Value: $524.7K |
||
|
Nov 20, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
2 033 Value: $90.1K |
||
|
Nov 20, 2025 Sell |
Stanton Marshall S. SVP, Clinical & Md Affair |
1 355 Value: $60.0K |
||
|
Nov 20, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
1 355 Value: $14.9K |
||
|
Nov 20, 2025 Buy |
Stanton Marshall S. SVP, Clinical & Md Affair |
2 033 Value: $37.5K |
||
|
Nov 18, 2025 Sell |
Hoff Elizabeth A Director |
4 200 Value: $189.4K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
